Latest Cancer vaccine Stories
SAN DIEGO, March 26, 2015 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
SEATTLE, Mar. 25, 2015 /PRNewswire/ --TapImmune Inc.
BETHESDA, Md., March 24, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies
- Duke Cancer Institute researchers publish Phase 1/2 study results in Nature providing human proof-of-concept for new solid tumor target and "immune pre-conditioning" approach to cancer immunotherapy.
New Therapy Will Harness the Power of Patients' Own Immune Systems to Fight Lung Cancer WASHINGTON, March 5, 2015 /PRNewswire-USNewswire/ -- LUNGevity Foundation, the nation's leading lung
SAN DIEGO, March 3, 2015 /PRNewswire/ -- MabVax Therapeutics (OTCQB: MBVX), a cancer diagnostic and immunotherapy company, announced today that David Hansen, the Company's President and CEO,
NEW YORK, Feb.
Move puts company in ideal position to attract top scientific and medical talent to advance OncoVAX® clinical trial BALTIMORE, Feb.
A Follow-On Combination Trial in First-Line Ovarian Cancer in the Neo-Adjuvant Setting Has Been Accepted by FDA LAWRENCEVILLE, N.J., Feb.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.